“A RANDOMIZED, OPEN-LABEL, PARALLEL, PROSPECTIVE STUDY COMPARING THE EFFECTIVENESS AND TOLERABILITY OF DULOXETINE, SERTRALINE, AND ESCITALOPRAM IN TREATING MAJOR DEPRESSIVE DISORDER”, Asian J. Med. Res. Health Sci., vol. 4, no. 1, pp. 203–208, Feb. 2026, doi: 10.65605/.